Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates

Moderna (MRNA) came out with a quarterly loss of $3.07 per share versus the Zacks Consensus Estimate of a loss of $3.59. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.48%. A quarter ago, it was expected that this biotechnology company would post a loss of $0.78 per share when it actually produced earnings of $0.55, delivering a surprise of 170.51%.Over the last four quarters, the company ...